台股 » 個股 » 易威 » 籌碼相關 » 主力籌碼集中度

易威

(1799)
  • 股價
    70.5
  • 漲跌
    ▼3.1
  • 漲幅
    -4.21%
  • 成交量
    379
  • 產業
    上櫃 生技醫療類股
  • 71人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-主力籌碼集中度
籌碼集中度

市場上除了三大法人之外,有些主力大戶在買賣股票的資訊並不會被揭露,而這些主力通常卻又是影響股票價格變動的主因。當主力反覆買進/賣出某支股票,則該股籌碼集中度就會變高/變低,而通常籌碼集中度越高,越有可能出現大行情。我們將主力在券商進出的數據做出統計,給您參考!

易威 (1799)主力籌碼與董監持股比重走勢圖

Created with Highstock 1.3.7嗨投資 histock.tw籌碼集中度外資籌碼大戶籌碼董監持股2020/07/012021/01/012021/07/012022/01/012022/07/012023/01/012023/07/012024/01/012024/07/012025/01/01-25%0%25%50%75%100%125%
Created with Highstock 1.3.7嗨投資 histock.tw籌碼集中度收盤價2020/07/012021/01/012021/07/012022/01/012022/07/012023/01/012023/07/012024/01/012024/07/012025/01/0160%70%80%90%100%110%-100元0元100元200元300元
Created with Highstock 1.3.7嗨投資 histock.tw外資籌碼收盤價2020/07/012021/01/012021/07/012022/01/012022/07/012023/01/012023/07/012024/01/012024/07/012025/01/01-5%0%5%10%15%20%-100元0元100元200元300元
Created with Highstock 1.3.7嗨投資 histock.tw大戶籌碼收盤價2020/07/012021/01/012021/07/012022/01/012022/07/012023/01/012023/07/012024/01/012024/07/012025/01/0140%50%60%70%80%90%-100元0元100元200元300元

易威 (1799)主力籌碼集中度 歷史資料

日期籌碼
集中度
外資
籌碼
大戶
籌碼
董監
持股
2025/03/2868.66%14.13%54.53%31.23%
2025/03/2168.85%14.26%54.59%31.23%
2025/03/1468.92%14.34%54.58%31.23%
2025/03/0769.00%15.15%53.85%31.23%
2025/02/2769.05%15.01%54.04%31.23%
2025/02/2169.10%15.09%54.01%31.23%
2025/02/1469.17%15.20%53.97%31.23%
2025/02/0869.26%15.06%54.20%31.23%
2025/01/2469.31%15.09%54.22%31.21%
2025/01/1769.37%15.00%54.37%31.21%
2025/01/1069.79%15.44%54.35%31.21%
2025/01/0370.28%15.33%54.95%31.21%
2024/12/2770.38%15.40%54.98%31.21%
2024/12/2072.27%15.77%56.50%31.21%
2024/12/1372.73%16.36%56.37%31.21%
2024/12/0672.40%15.94%56.46%31.21%
2024/11/2973.03%15.86%57.17%31.21%
2024/11/2273.80%16.10%57.70%31.21%
2024/11/1572.95%15.73%57.22%31.21%
2024/11/0873.62%15.31%58.31%31.21%
2024/11/0173.82%15.15%58.67%31.21%
2024/10/2573.91%14.93%58.98%31.21%
2024/10/1874.39%14.77%59.62%31.21%
2024/10/1174.49%15.10%59.39%31.21%
2024/10/0475.43%15.45%59.98%31.21%
2024/09/2775.85%15.65%60.20%31.21%
2024/09/2075.46%14.67%60.79%31.21%
2024/09/1376.30%14.68%61.62%31.21%
2024/09/0675.99%14.58%61.41%31.21%
2024/08/3075.83%14.63%61.20%31.21%
2024/08/2375.47%14.80%60.67%31.21%
2024/08/1675.63%14.49%61.14%31.21%
2024/08/0975.47%14.43%61.04%31.21%
2024/08/0274.72%14.18%60.54%31.21%
2024/07/2674.29%14.38%59.91%31.21%
2024/07/1974.65%14.51%60.14%31.25%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音